These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
444 related items for PubMed ID: 27462777
1. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function. Okajima W, Komatsu S, Ichikawa D, Miyamae M, Kawaguchi T, Hirajima S, Ohashi T, Imamura T, Kiuchi J, Arita T, Konishi H, Shiozaki A, Moriumura R, Ikoma H, Okamoto K, Taniguchi H, Itoh Y, Otsuji E. Oncotarget; 2016 Aug 16; 7(33):53820-53836. PubMed ID: 27462777 [Abstract] [Full Text] [Related]
3. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma. Chen Y, Chen J, Liu Y, Li S, Huang P. Med Sci Monit; 2015 Jun 29; 21():1864-71. PubMed ID: 26119771 [Abstract] [Full Text] [Related]
4. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A, Ghosh A, Datta S, Dasgupta D, Das S, Ray S, Gupta S, Datta S, Chowdhury A, Chatterjee R, Mohapatra SK, Banerjee S. Int J Cancer; 2016 Jun 01; 138(11):2732-44. PubMed ID: 26756996 [Abstract] [Full Text] [Related]
5. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Wen Y, Han J, Chen J, Dong J, Xia Y, Liu J, Jiang Y, Dai J, Lu J, Jin G, Han J, Wei Q, Shen H, Sun B, Hu Z. Int J Cancer; 2015 Oct 01; 137(7):1679-90. PubMed ID: 25845839 [Abstract] [Full Text] [Related]
6. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation. Ng KT, Lo CM, Wong N, Li CX, Qi X, Liu XB, Geng W, Yeung OW, Ma YY, Chan SC, Man K. Oncotarget; 2016 Apr 12; 7(15):19824-39. PubMed ID: 26918346 [Abstract] [Full Text] [Related]
12. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening. Jiang L, Li X, Cheng Q, Zhang BH. Tumour Biol; 2015 Sep 12; 36(9):7167-74. PubMed ID: 25894380 [Abstract] [Full Text] [Related]
13. MicroRNA signature in hepatocellular carcinoma patients: identification of potential markers. Elhendawy M, Abdul-Baki EA, Abd-Elsalam S, Hagras MM, Zidan AA, Abdel-Naby AY, Watny M, Elkabash IA, Salem ML, Elshanshoury M, Soliman S, Abdou S. Mol Biol Rep; 2020 Jul 12; 47(7):4945-4953. PubMed ID: 32430845 [Abstract] [Full Text] [Related]
14. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma. Sohn W, Kim J, Kang SH, Yang SR, Cho JY, Cho HC, Shim SG, Paik YH. Exp Mol Med; 2015 Sep 18; 47(9):e184. PubMed ID: 26380927 [Abstract] [Full Text] [Related]
18. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Chen L, Chu F, Cao Y, Shao J, Wang F. Tumour Biol; 2015 Sep 18; 36(10):7439-47. PubMed ID: 25903466 [Abstract] [Full Text] [Related]
19. Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers. Mirzaei HR, Sahebkar A, Mohammadi M, Yari R, Salehi H, Jafari MH, Namdar A, Khabazian E, Jaafari MR, Mirzaei H. Curr Pharm Des; 2016 Sep 18; 22(34):5257-5269. PubMed ID: 26935703 [Abstract] [Full Text] [Related]